Atrial tachycardia
diseaseOn this page
Summary
Atrial tachycardia (MONDO:0005479) is a disease and 34 clinical trials. Top therapeutic interventions include amiodarone, sodium chloride, and magnesium. A subtype of cardiac rhythm disease — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Clinical trials: 34
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | atrial tachycardia |
| Mondo ID | MONDO:0005479 |
| EFO | EFO:0005308 |
| NCIT | C35481 |
| SNOMED CT | 276796006 |
| UMLS | C0546959 |
| MedGen | 107485 |
| Is cancer (heuristic) | no |
Disease family
This is a subtype of cardiac rhythm disease. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › cardiovascular disorder › heart disorder › cardiac rhythm disease › atrial tachycardia
Related subtypes (16): ventricular fibrillation, cardiac arrest, atrial fibrillation, ventricular tachycardia, torsade-de-pointes syndrome with short coupling interval, sinoatrial node dysfunction and deafness, sino-auricular heart block, multifocal atrial tachycardia, His bundle tachycardia, incessant infant ventricular tachycardia, ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome, sudden arrhythmia death syndrome, cardiac conduction defect, sudden cardiac arrest, cardiac conduction disease with or without cardiomyoopathy, cardiogenetic rhythm disorder
Subtypes (1): atrial flutter
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 34.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 33 |
| PHASE3 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT06376916 | PHASE3 | RECRUITING | Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR |
| NCT03209583 | Not specified | RECRUITING | ATrial Tachycardia PAcing Therapy in Congenital Heart |
| NCT03915691 | Not specified | ACTIVE_NOT_RECRUITING | The RIPPLE AT-PLUS Study |
| NCT05014802 | Not specified | RECRUITING | Baseline Atrial Fibrosis Predicts Risk for Post-operative Atrial Fibrillation in Patients Undergoing Cardiac Surgery |
| NCT05239364 | Not specified | RECRUITING | Ablation of Consecutive Atrial Tachycardia |
| NCT05434650 | Not specified | ACTIVE_NOT_RECRUITING | Abbott Atrial Fibrillation Post Approval Study |
| NCT05521451 | Not specified | RECRUITING | Clinical Cohort Study - TRUST |
| NCT05526170 | Not specified | ACTIVE_NOT_RECRUITING | Triggers and Risk Factors for Recurrence of Atrial Arrhythmias With the Use of Long-term Monitoring |
| NCT05883631 | Not specified | ACTIVE_NOT_RECRUITING | RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy. |
| NCT06969378 | Not specified | NOT_YET_RECRUITING | Empiric Pulsed Field Pulmonary Vein Isolation During Atrial Tachycardia Ablation in Adults With Congenital Heart Disease |
| NCT07079813 | Not specified | NOT_YET_RECRUITING | Clinical Study on the Efficiency of Rapid Arrhythmia Mapping Using EasyStars™ High Density Mapping Catheter Applications |
| NCT07109141 | Not specified | RECRUITING | Registry of Atrial Arrhythmia Ablation Procedures Using Pulsed Field Ablation in Poland |
| NCT07239804 | Not specified | ACTIVE_NOT_RECRUITING | Systematic Assessment of Treatment Effectiveness for Long-Term Management of Stable Atrial Tachycardia in Inpatient and Outpatient Environments |
| NCT00247351 | Not specified | COMPLETED | Prevention of Atrial Tachycardia After a Right Atriotomy |
| NCT01108692 | Not specified | COMPLETED | Strategy of Early Detection and Active Management of Supraventricular Arrhythmia With Telecardiology (SETAM) |
| NCT02374359 | Not specified | UNKNOWN | Atrial Tachycardia as a Predictor of Atrial Fibrillation, Stroke and Mortality in Cryptogenic Stroke |
| NCT02451995 | Not specified | COMPLETED | Effectiveness of Ripple Mapping in Atrial Tachycardia Ablation |
| NCT03151278 | Not specified | COMPLETED | Zero Fluoroscopic Ablation Versus Conventional Fluoroscopic Ablation for Right Atrial Arrhythmias |
| NCT03343860 | Not specified | COMPLETED | Catheter Ablation of All Inducible AT Post AF Ablation |
| NCT03365440 | Not specified | COMPLETED | Esophageal 3D Mapping System for Cardiac Arrhythmias |
| NCT03376438 | Not specified | COMPLETED | Prospective Observational Cohort Study of Fetal Atrial Flutter & Supraventricular Tachycardia |
| NCT03413150 | Not specified | COMPLETED | Modeling of Amiodarone Effect on Heart Rate Control in Critically Ill Patients With Atrial Tachyarrhythmias |
| NCT03549806 | Not specified | COMPLETED | Stanford Cardiac Invasive Electrophysiology Novel Computer Experience |
| NCT03750435 | Not specified | UNKNOWN | Non-fluoroscopy Ablation of AF/AT |
| NCT03816033 | Not specified | UNKNOWN | Cryotherapy Versus Radiofrequency Catheter Ablation Research Program |
| NCT04162249 | Not specified | COMPLETED | High Radiofrequency Power for Faster and Safer Pulmonary Veins Isolation - a Pilot Observational Study. |
| NCT04198220 | Not specified | COMPLETED | BIO|STREAM.ICM Obesity |
| NCT04919902 | Not specified | UNKNOWN | Prague Registry of Electric Cardioversion |
| NCT05344456 | Not specified | COMPLETED | PVC Response ‘‘Atrial Pace’’ Inducing Atrial Tachycardias |
| NCT05362656 | Not specified | COMPLETED | AutoMatic disPERsion Tagging Function Preliminary Evaluation |
| NCT05765565 | Not specified | UNKNOWN | Comparison Between the Octaray and Pentaray Catheters in Patients Undergoing Ablation for Atrial Tachycardia. |
| NCT05802576 | Not specified | COMPLETED | Study of Interference Between Oral Anticoagulants and Heparin During Ablation of Atrial Fibrillation (AF) or Left Atrial Tachycardia (GAD) by Catheter. |
| NCT06327425 | Not specified | UNKNOWN | MCG for Localization of Tachyarrhythmia’s Origin |
| NCT06335446 | Not specified | COMPLETED | Identification, Electro-mechanical Characterisation and Ablation of Driver Regions in Persistent Atrial Fibrillation |
Drugs tested across these trials (top 30)
| Molecule | Max phase | Trials referencing |
|---|---|---|
| AMIODARONE | 4 | 3 |
| SODIUM CHLORIDE | 4 | 1 |
| MAGNESIUM | 3 | 1 |
Related Atlas pages
- Drugs: Amiodarone, Sodium Chloride, Magnesium